drugset
drugset / Trial / NCT05320861

Single Dose ADME Study of [14C]SJP-0008 in Healthy Male Subjects

NCT05320861 ↗

Phase 1 Completed 6 enrolled Senju Pharmaceutical Co., Ltd. Quotient Sciences · collab
NaSingle-groupOpen-labelTreatment

Summary

This single centre, open-label, non-randomised, single period, single-dose study in healthy male subjects was designed and conducted to assess the mass balance recovery, PK, metabolite profile and metabolite identification of SJP-0008.

Timeline

Start
2021-09-24
Primary completion
2021-11-02
Completion
2021-11-02

Drugs

EvaluationDrugModalityDoseRoute
Subject SJP-0008 Unknown — Oral

Indications

No indication recorded.